Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on April 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Intent to Sole Source - Preventative Maintenance Agreement for 4 Apheresis Machines (Optias)

Closed
NOI-OLAO-CC-26-005158Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 339112
New
Federal
6515--New Base+4 Hologic Genesis Processors Service Agreement (VA-26-00073009)The Department of Veterans Affairs, through its Network Contracting Office 12 at the Great Lakes Acquisition Center, plans to enter into a single source procurement with Adaptive Technology Resources, Inc. for Custom Bed Controllers. This acquisition is being conducted under FAR 13.106-1(b), which allows for a non-competitive procurement process. Although the government intends to award the contract without competition, other interested entities may express their interest and capabilities by submitting a response by June 22, 2026, at 7:00 a.m. CST. Responses received will be considered to determine whether to proceed with a competitive procurement, but the decision to do so remains at the sole discretion of the government. No solicitation documents are currently available, and the government will not cover any costs incurred during the preparation of responses. This opportunity falls under the North American Industry Classification System code 339112, which pertains to small businesses engaged in Surgical and Medical Instrument Manufacturing. All questions or comments related to this notice should be directed via email to Vernise L. Newton, the contract specialist, by the stated deadline with the subject line referencing the Notice of Intent from SAM.gov. The contract referenced in this notice is titled "6515--New Base+4 Hologic Genesis Processors Service Agreement (VA-26-00073009)" and was posted on June 16, 2026, with responses due by the end of June 22, 2026. The contracting office is located in Milwaukee, Wisconsin.
252-NETWORK Contract Office 12 (36C252)

POSTED

1 day ago

DEADLINE

in 5 days

AI Contract Overview

Show more

The National Institutes of Health Clinical Center (NIH-CC) intends to negotiate a sole-source contract with Terumo BCT for a preventative maintenance and service agreement covering four apheresis machines (Optias) used in patient care. This agreement is planned for an initial one-year period with two additional option years. The apheresis machines are critical for extracorporeal therapy, separating blood and blood components from donors and patients, supporting various clinical protocols and treatments. Due to the unique nature of this equipment and regulatory requirements from agencies such as the FDA and AABB for maintenance and care, the NIH has determined that only one responsible source can meet the agency’s specific needs. This acquisition will proceed on an other than full and open competition basis under the authority of FAR 6.302-1 and statutory authority 41 U.S.C. 253(c)(1). While this notice does not constitute a request for proposal, other responsible sources interested in providing these services may submit capability statements for consideration by the deadline of May 13, 2026. The government will review any submissions but retains discretion over whether to proceed with competition. The contract will be managed through the NIH Office of Purchasing and Contracts on behalf of the Clinical Center’s Blood Services Section, with performance based in Bethesda, Maryland.

General Info

NIH plans sole-source contract with Terumo BCT for one-year maintenance of four critical apheresis machines.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

339112 - Surgical and Medical Instrument Manufacturing View NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(2)

Optia+PM.Service+JOFOC+2026+4.docx

DOCX

Optia+service+contract+SOW+2026+2+Optia+2.docx

DOCX

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
ContactsNo contacts available
OfficeBethesda, MD, 20892, US
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
Office AddressBethesda, MD, 20892, US
ContactsNo contact information available

Full Description

Show more

This is a Notice of Intent, not a request for proposal.  The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Terumo BCT.


Acquisition Descripton:


The National Institutes of Health, Office of Purchasing and Contracts on behalf of Clinical Center (CC), Blood Services Section (BSS) has a need to approve a "Justification for Other Than Full and Open" requirement in accordance with FAR 8.3, Other Than Full and Open Competition.


This procurement action in accordance with IAW FAR 6.302-1 is based on the need to procure a service agreement for our apheresis machines which are used in a patient care capacity. Service Agreement is for a one-year period with the two option years.


Approval of this purchase is for service agreement for a specific type of instrument which is used to separate blood and blood products on donors and patients in the NIH Clinical Center.


The DTM is a unique blood center which collects blood and blood components from healthy donors for patients participating in many protocols. However, blood and blood products are also withdrawn from patients when prescribed by a physician, which may have a therapeutic benefit to treat their medical condition. These two (2) apheresis machines are used to perform extracorporeal therapy in which the blood of donors or patients is passed through the device to separate blood components. Numerous regulatory authorities, specifically the Food and Drug Administration (FDA) and AABB set policy and enforce this policy for care and maintenance of equipment that is used, in support of donors and patients per the above.


The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-26-005158) by 12:00 PM eastern standard time on 05/13/2026 to: valerie.gregorio@nih.gov.


All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.